Pharmacoeconomic analysis of microbiologic techniques for differentiating staphylococci directly from blood culture bottles.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2546718)

Published in J Clin Microbiol on July 09, 2008

Authors

Elizabeth D Hermsen1, Sara S Shull, Donald G Klepser, Peter C Iwen, Amy Armbrust, Jodi Garrett, Alison G Freifeld, Mark E Rupp

Author Affiliations

1: Department of Pharmaceutical and Nutrition Care, The Nebraska Medical Center, 988485 Nebraska Medical Center, Omaha, Nebraska 68198-8485, USA. ehermsen@nebraskamed.com

Articles cited by this

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis (2002) 11.30

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest (2000) 9.51

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40

Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA (1991) 6.28

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol (2005) 5.86

Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis (1994) 3.88

Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J Clin Microbiol (2002) 3.40

Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis (2000) 3.01

Blood culture contamination: persisting problems and partial progress. J Clin Microbiol (2003) 2.62

Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother (2006) 2.57

Antimicrobial misuse in patients with positive blood cultures. Am J Med (1989) 2.45

Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust (2001) 2.33

Evaluation of three rapid methods for the direct identification of Staphylococcus aureus from positive blood cultures. J Clin Microbiol (2003) 1.93

Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis (2001) 1.50

Blood culture contamination: a College of American Pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients. Arch Pathol Lab Med (1998) 1.40

Rapid detection of methicillin-resistant staphylococci by real-time PCR directly from positive blood culture bottles. Eur J Clin Microbiol Infect Dis (2007) 1.01

Use of real-time polymerase chain reaction for identification of methicillin-resistant Staphylococcus aureus directly from positive blood culture bottles. Diagn Microbiol Infect Dis (2007) 0.98

Coagulase-negative staphylococcal infections: an update regarding recognition and management. Curr Clin Top Infect Dis (1997) 0.79

Articles by these authors

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53

Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis (2007) 5.51

Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control (2011) 4.59

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med (2005) 4.27

Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis (2011) 4.09

Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units . Infect Control Hosp Epidemiol (2008) 4.03

Healthcare personnel attire in non-operating-room settings. Infect Control Hosp Epidemiol (2014) 3.10

Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis (2011) 2.49

Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror (2006) 2.43

Coagulase-negative staphylococcal infections. Infect Dis Clin North Am (2009) 2.14

The neutropenic diet reviewed: moving toward a safe food handling approach. Oncology (Williston Park) (2012) 2.14

West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. Clin Infect Dis (2004) 1.84

Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis (2009) 1.80

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis. Crit Care Med (2010) 1.58

Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun (2010) 1.54

Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity. Crit Care Med (2004) 1.48

Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant (2007) 1.39

Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2008) 1.36

Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw (2012) 1.35

Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis (2011) 1.34

Phialosimplex, a new anamorphic genus associated with infections in dogs and having phylogenetic affinity to the Trichocomaceae. Med Mycol (2010) 1.24

Proton pump inhibitors and acute kidney injury: a nested case-control study. BMC Nephrol (2013) 1.23

Myeloid growth factors. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 1.23

Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.18

Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis (2005) 1.17

Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 1.17

Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis (2007) 1.16

Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy (2009) 1.15

Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol (2006) 1.12

KPC-4 Is encoded within a truncated Tn4401 in an IncL/M plasmid, pNE1280, isolated from Enterobacter cloacae and Serratia marcescens. Antimicrob Agents Chemother (2012) 1.08

PCR rapidly detects methicillin-resistant staphylococci periprosthetic infection. Clin Orthop Relat Res (2003) 1.07

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Expert Opin Drug Saf (2010) 1.06

Adherence and dosing frequency of common medications for cardiovascular patients. Am J Manag Care (2012) 1.06

Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy. PLoS One (2009) 1.05

Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care (2011) 1.04

Validation of the Cepheid Xpert Flu A real time RT-PCR detection panel for emergency use authorization. J Clin Virol (2010) 1.03

Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. J Clin Microbiol (2010) 1.03

Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system. J Clin Microbiol (2004) 1.02

Ethanol lock technique: review of the literature. Infect Control Hosp Epidemiol (2009) 1.01

Implementation of a clinical decision support system for antimicrobial stewardship. Infect Control Hosp Epidemiol (2012) 1.00

Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery. Infect Control Hosp Epidemiol (2009) 0.99

Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia. Clin Infect Dis (2008) 0.99

Leuconostoc bacteremia in pediatric patients with short bowel syndrome: case series and review. Pediatr Infect Dis J (2008) 0.99

Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis. BMJ Open (2013) 0.99

Mucor circinelloides was identified by molecular methods as a cause of primary cutaneous zygomycosis. J Clin Microbiol (2006) 0.98

Antibacterial prophylaxis in patients with neutropenia. J Natl Compr Canc Netw (2007) 0.96

New developments in the prevention of intravascular catheter associated infections. Infect Dis Clin North Am (2012) 0.95

An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health (2005) 0.94

Myeloid growth factors. J Natl Compr Canc Netw (2009) 0.94

From physician intent to the pharmacy label: prevalence and description of discrepancies from a cross-sectional evaluation of electronic prescriptions. BMJ Qual Saf (2013) 0.93

Large direct repeats flank genomic rearrangements between a new clinical isolate of Francisella tularensis subsp. tularensis A1 and Schu S4. PLoS One (2010) 0.93

Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and -independent Staphylococcus epidermidis biofilm. J Antimicrob Chemother (2010) 0.92

Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation (2008) 0.92

Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies. Clin Infect Dis (2002) 0.92

Francisella tularensis molecular typing using differential insertion sequence amplification. J Clin Microbiol (2011) 0.92

Decontamination of a hospital room using gaseous chlorine dioxide: Bacillus anthracis, Francisella tularensis, and Yersinia pestis. J Occup Environ Hyg (2013) 0.91

Student-run low-income family medicine clinic: controlling costs while providing comprehensive medication management. J Am Pharm Assoc (2003) (2010) 0.90

Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.89

Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature. Clin Transplant (2008) 0.87

Susceptibility of enterococci to daptomycin is dependent upon testing methodology. Diagn Microbiol Infect Dis (2013) 0.87

Molecular identification of Mycobacterium chimaera as a cause of infection in a patient with chronic obstructive pulmonary disease. Diagn Microbiol Infect Dis (2009) 0.87

Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia. J Clin Microbiol (2005) 0.87

Comparison of traditional phenotypic identification methods with partial 5' 16S rRNA gene sequencing for species-level identification of nonfermenting Gram-negative bacilli. J Clin Microbiol (2010) 0.87

Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis. J Clin Microbiol (2010) 0.87

Evaluation of ambulance decontamination using gaseous chlorine dioxide. Prehosp Emerg Care (2013) 0.86

Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials. Pharmacotherapy (2009) 0.86

Utilization of the relative complexity measure to construct a phylogenetic tree for fungi. Mycol Res (2004) 0.86

Public disclosure of healthcare-associated infections: the role of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (2005) 0.85

No place like home? Outpatient management of patients with febrile neutropenia and low risk. J Clin Oncol (2011) 0.85

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry. Mycoses (2014) 0.85

Bacteremia caused by Microbacterium binotii in a patient with sickle cell anemia. J Clin Microbiol (2013) 0.84

Delayed diagnosis of osseous blastomycosis in two patients following environmental exposure in nonendemic areas. Am J Clin Pathol (2002) 0.84

Impact of chlorine dioxide gas sterilization on nosocomial organism viability in a hospital room. Int J Environ Res Public Health (2013) 0.84

Applying a real-time PCR assay for Histoplasma capsulatum to clinically relevant formalin-fixed paraffin-embedded human tissue. J Clin Microbiol (2012) 0.84

Computational approach involving use of the internal transcribed spacer 1 region for identification of Mycobacterium species. J Clin Microbiol (2005) 0.84

Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 0.84

The effect of physician and health plan market concentration on prices in commercial health insurance markets. Int J Health Care Finance Econ (2008) 0.83

Inappropriate use of urinary catheters: a prospective observational study. Am J Infect Control (2011) 0.83

Population-based medication reviews: a descriptive analysis of the medication issues identified in a medicare not-for-profit prescription discount program. Ann Pharmacother (2004) 0.83

Mycobacterium nebraskense sp. nov., a novel slowly growing scotochromogenic species. Int J Syst Evol Microbiol (2004) 0.82

Surrogate testing suggests that chlorine dioxide gas exposure would not inactivate Ebola virus contained in environmental blood contamination. J Occup Environ Hyg (2015) 0.82

Impact of adenosine triphosphate detection and feedback on hospital room cleaning. Infect Control Hosp Epidemiol (2014) 0.81

A model of tuberculosis transmission and intervention strategies in an urban residential area. Comput Biol Chem (2010) 0.81

Infection control experience in a cooperative care center for transplant patients. Infect Control Hosp Epidemiol (2008) 0.81

Cytomegalovirus viremia in solid organ transplantation: does the initial viral load correlate with risk factors and outcomes? Clin Transplant (2008) 0.81

Implications of culture-independent panel-based detection of Cyclospora cayetanensis. J Clin Microbiol (2013) 0.81

Improvement in prescribing habits and economic outcomes associated with the introduction of a standardized approach for surgical antimicrobial prophylaxis. Infect Control Hosp Epidemiol (2008) 0.81

Zygomycosis. Semin Respir Crit Care Med (2004) 0.81

Adenovirus infections in pediatric small bowel transplant recipients. Transplantation (2010) 0.80

Factors affecting demand among older adults for medication therapy management services. Res Social Adm Pharm (2008) 0.80

Infectious Disease Physicians' Perceptions About Ebola Preparedness Early in the US Response: A Qualitative Analysis and Lessons for the Future. Health Secur (2016) 0.79

Antimicrobial stewardship in outpatient settings: leveraging innovative physician-pharmacist collaborations to reduce antibiotic resistance. Health Secur (2015) 0.79

A case study on decontamination of a biosafety level-3 laboratory and associated ductwork within an operational building using gaseous chlorine dioxide. J Occup Environ Hyg (2012) 0.79